Research presented today at the American College of Cardiology's 57th Annual Scientific Session suggests that physicians should prescribe the lowest doses of Celecoxib possible, especially in higher risk patients.
Video from: clipsyndicate.com
CARDIOVASCULAR RISK ASSOCIATED WITH COX-2 INHIBITOR DIFFERS BY DOSE
|
|||
Research presented today at the American College of Cardiology's 57th Annual Scientific Session suggests that physicians should prescribe the lowest doses of Celecoxib possible, especially in higher risk patients. Video from: clipsyndicate.com |
|||
 |
